Drug information for CAVERJECT

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 0.005MG/VIAL Prescription   ALPROSTADIL Alprostadil PHARMACIA AND UPJOHN 20379
2003-09-09 Letter

2002-01-15 Letter

1998-03-26 Review
INJECTABLE; INJECTION 0.01MG/VIAL Prescription AP  ALPROSTADIL Alprostadil PHARMACIA AND UPJOHN   "
INJECTABLE; INJECTION 0.02MG/VIAL Prescription AP (Reference Drug) ALPROSTADIL Alprostadil PHARMACIA AND UPJOHN   "
INJECTABLE; INJECTION 0.04MG/VIAL Prescription AP (Reference Drug) ALPROSTADIL Alprostadil PHARMACIA AND UPJOHN   "
INJECTABLE; INJECTION 0.005MG/ML Discontinued   ALPROSTADIL Alprostadil PFIZER 20755
2003-09-09 Letter

2003-08-07 Review
INJECTABLE; INJECTION 0.01MG/ML Discontinued   ALPROSTADIL Alprostadil PFIZER   "
INJECTABLE; INJECTION 0.02MG/ML Discontinued   ALPROSTADIL Alprostadil PFIZER   "

Drug Adverse Effects information for CAVERJECT

Role code Indications Reaction # Reports
PS BLOOD CHOLESTEROL INCREASED DIABETIC NEUROPATHY 1
PS DIABETES MELLITUS DIABETIC NEUROPATHY 5
PS ERECTILE DYSFUNCTION DIABETIC NEUROPATHY 1
PS ERECTILE DYSFUNCTION DRUG INEFFECTIVE 1
PS GASTROOESOPHAGEAL REFLUX DISEASE DIABETIC NEUROPATHY 1
PS HYPERTENSION DRUG INEFFECTIVE 3
PS HYPERTENSION ERECTION INCREASED 1
PS HYPERTENSION PAIN 1
PS HYPERTENSION WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
PS LIBIDO DISORDER ANTIANDROGEN THERAPY 1
PS LIBIDO DISORDER DRUG INEFFECTIVE 1
PS LIBIDO DISORDER PROSTATIC SPECIFIC ANTIGEN INCREASED 1
PS PROSTATIC DISORDER DIABETIC NEUROPATHY 1
PS RADICAL PROSTATECTOMY ANTIANDROGEN THERAPY 1
PS RADICAL PROSTATECTOMY DRUG INEFFECTIVE 1
PS RADICAL PROSTATECTOMY PROSTATIC SPECIFIC ANTIGEN INCREASED 1
PS UROGENITAL DISORDER PEYRONIE'S DISEASE 1
Ads by Google